Skip to main content
Equibles

OGI · Organigram Global Inc. · Documents

Use OGI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OGI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1.2500 CAD -0.0300 (-2.34%) At close · Nov 6 Intraday price with Plus
Rebalance outlook locked

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Annual report FY2025 Revenue 259.18M CAD up 62.2% 40-F filed Dec 16, 2025 Earnings call Q3 2026 earnings call Held Aug 11, 2026
2026
Nov 3
Current report 6-K
Organigram to acquire Aurora for C$7.80 per share

Organigram Global Inc. agreed to acquire Aurora Cannabis Inc. for C$7.80 per Aurora common share, valuing Aurora at approximately C$561 million on a fully diluted equity basis. The transaction is expected to complete in January 2027, subject to approvals.

3 source passages
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram”) and Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (“Aurora”) today announced that they have entered into an arrangement agreement (the “Arrangement Agreement”) pursuant to which Organigram will acquire all of the issued and outstanding common shares (the “Aurora Shares”) of Aurora at a price of C$7.80 per Aurora Common Share (the “Transaction”). The Transaction values Aurora at approximately C$561 million on a fully diluted equity value basis. Subject to the satisfaction of such conditions, the Transaction is expected to be completed in January 2027. Open the document at this passage
Oct 15
Current report 6-K
Current report

Organigram Global Inc. completed the Sanity Group integration and expects $8 million to $10 million in annualized run-rate cost savings in Fiscal 2027, with $5 million to $6 million expected in Fiscal 2027 and $2 million in one-time costs.

Sep 30
Current report 6-K
Current report

Organigram Global Inc. announced that its 2026 OG Investor Session will premiere on September 30, 2026, at 4:00 p.m. ET on X, with presentations from senior leadership, an operations overview and a management fireside Q&A.

Aug 11
Report SEDAR+
MD&A
May 12
Report SEDAR+
MD&A
Apr 27
Offering documents SEDAR+
1 offering document
  • Report of exempt distribution excluding Schedule 1 of 45-106F1 1
Showing 1–50 of 915 documents